MINERALYS

Serial Number 88948333
Registration 6457099
700

Registration Progress

Application Filed
Jun 4, 2020
Under Examination
Dec 8, 2020
Approved for Publication
Oct 13, 2020
Published for Opposition
Oct 13, 2020
Registered
Aug 17, 2021

Trademark Image

MINERALYS

Basic Information

Serial Number
88948333
Registration Number
6457099
Filing Date
June 4, 2020
Registration Date
August 17, 2021
Published for Opposition
October 13, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 17, 2021
Registration
Registered
Classes
005 042

Rights Holder

Mineralys Therapeutics, Inc.

03
Address
Suite F200
150 N. Radnor Chester Road
Radnor, PA 19087

Ownership History

Mineralys Therapeutics, Inc.

Original Applicant
03
San Francisco, CA

Mineralys Therapeutics, Inc.

Owner at Publication
03
Radnor, PA

Mineralys Therapeutics, Inc.

Original Registrant
03
Radnor, PA

Legal Representation

Attorney
David P. Goldberg

USPTO Deadlines

Next Deadline
581 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20210817)
Due Date
August 17, 2027
Grace Period Ends
February 17, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Sep 8, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 8, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 8, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 8, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 8, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 17, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 13, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jul 10, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 7, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jun 24, 2021 IUAF S USE AMENDMENT FILED Loading...
Jul 6, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 24, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 8, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 4, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 4, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 8, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 13, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 13, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 23, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 9, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 9, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 9, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 9, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Sep 9, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 7, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 25, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 8, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of hormonal disorders; cardiovascular pharmaceutical preparations; pharmaceutical preparations for treating hypertension
First Use Anywhere: Jun 11, 2021
First Use in Commerce: Jun 11, 2021
Class 042
Research in the field of pharmaceuticals; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; research on the subject of pharmaceuticals; drug discovery services; pharmaceutical research services; development of pharmaceutical preparations and medicine; medical research; chemical research; chemistry services; chemical analysis; biological research; scientific research; scientific laboratory services
First Use Anywhere: Jul 27, 2020
First Use in Commerce: Jul 27, 2020

Classification

International Classes
005 042